News | PET-CT | November 18, 2015

Mirada Medical Providing Imaging Software for Cancer Diagnostics Across England

Company will deploy XD3 Advanced image review and analysis software at 30 National Health Service PET/CT departments

Mirada Medical, Alliance Medical, NHS, National Health Service, United Kingdom, PET/CT, cancer diagnostics

November 18, 2015 — Mirada Medical Ltd has announced that its XD3 Advanced image review and analysis software is being deployed by Alliance Medical in partnership with 30 National Health Service (NHS) hospital positron emission tomography/computed tomography (PET/CT) departments nationwide.

In January 2015 the NHS selected a collaborative network, led by Alliance Medical, to provide PET/CT scanning services across the country, following a competitive tender process.

The network also involves a number of leading academic institutions, including The Christie NHS Foundation Trust and Leeds Teaching Hospitals NHS Trust, as well as local NHS and charitable partners. 

PET/CT imaging is critical for accurate diagnosis, staging and follow-up of many cancers. It enables treating clinicians to see precisely where the tumors are located and how they change or spread over the course of the disease and its treatment. More than 50,000 PET/CT scans are read in England each year. Mirada's XD3 software provides powerful tools to combine quantification information from these scans, enabling clinicians to confidently assess their patients.

As part of the contract Oxford-based Mirada Medical are delivering their diagnostic imaging software, XD3 Advanced, to the whole collaborative network.

“Mirada’s XD3 software provides a robust reporting solution with state-of-the-art features facilitating quantitative data analysis. It is a reliable and efficient platform for PET/CT reporting that gives confidence in image interpretation. This is key to the assessment and treatment efficacy and effective ongoing cancer care,” said Andrew Scarsbrook, M.D., consultant radiologist and nuclear medicine physician, Leeds Teaching Hospitals NHS Trust.

“Alliance Medical believes that our PET/CT collaborative network, together with Mirada Medical software, will result in the highest quality clinical analysis combined with improvements in productivity and associated cost,” said Johann Alberts, M.D., director of PET/CT operations, Alliance Medical.

Mirada's software products are available to the NHS and to thousands of users throughout the world under its own brand, and on an OEM basis through select global leading healthcare companies.

For more information:

Related Content

FDA Clears CereMetrix’s Neuroimaging Analytics and Clinical Workflow Platform
Technology | Neuro Imaging | March 15, 2018
March 15, 2018 – CereMetrix, a subsidiary of CereHealth Corp., ha
Siemens Healthineers Launches New Partners for Digital Ecosystem at HIMSS 2018
News | PACS Accessories | March 12, 2018
At the 2018 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition, March 5-9...
News | Business | March 08, 2018
Scranton Gillette Communications’ Imaging Technology News (ITN) was recently named a 2018 Azbee Award finalist in five...
In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows).

In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows). Image courtesy of A Piccardo et al., Galliera Hospital, Genoa, Italy.

News | Prostate Cancer | March 07, 2018
An Italian study featured in the March i
Enterprise imaging is evolving to address the problem — to find and assemble relevant information so that accurate diagnoses can be made efficiently and effectively
Feature | Enterprise Imaging | March 06, 2018 | By Jeff Zagoudis
Physicians are struggling with too much of a good thing. They have never had so much information about their patients....
ContextVision Demonstrates VolarView and the Orthopedic Package at ECR 2018
Technology | Advanced Visualization | February 27, 2018
At this year’s European Congress of Radiology (ECR), Feb. 28-March 4 in Vienna, Austria, ContextVision will showcase...
Sponsored Content | Videos | Women's Health | February 27, 2018
Fujifilm details its latest innovations in women's health including its ASPIRE Cristalle mammography system with...
Sponsored Content | Videos | Pediatric Imaging | February 22, 2018
FUJIFILM Medical Systems U.S.A., Inc. and FUJIFILM SonoSite Inc., are offering a full-suite pediatric solutions...
Sponsored Content | Videos | Flat Panel Displays | February 21, 2018
This 5 megapixel, high-brightness color monitor has the high-definition display necessary for breast imaging.
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
Overlay Init